# FDA Inspection 1303256 - Cardinal Health #414 LLC - January 28, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/cardinal-health-414-llc/14f06f69-e45c-4bf4-a74b-2503a84fd3fc/
Source feed: FDA_Inspections

> FDA Inspection 1303256 for Cardinal Health #414 LLC on January 28, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303256
- Company Name: Cardinal Health #414 LLC
- Inspection Date: 2026-01-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1303256 - 2026-01-28](https://www.globalkeysolutions.net/api/records/fda_inspections/cardinal-health-414-llc/98e45f28-f0b4-4f4e-b31f-f1ef441940da/)
- [FDA Inspection 926122 - 2015-05-13](https://www.globalkeysolutions.net/api/records/fda_inspections/cardinal-health-414-llc/f81eb1af-0ece-4b89-86cb-b7ef2f525135/)
- [FDA Inspection 705774 - 2011-01-14](https://www.globalkeysolutions.net/api/records/fda_inspections/cardinal-health-414-llc/cd1c469c-5f2f-4dcc-9227-11f7c7b474d5/)

Company: https://www.globalkeysolutions.net/companies/cardinal-health-414-llc/77c4beb4-8fbe-47f5-89f3-0bf6cbc68a95

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c